Cerebral to pay nearly $3.7M over controlled substance prescribing practices

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

FTC investigates Teva over patents, doubling down on ‘bogus’ Orange Book listings

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 2, 2024

Athos, an autoimmune and cancer biotech, is raising $35M for clinical trials

Athos Therapeutics is raising a $35 million Series B, it confirmed to Endpoints News. The Torrance, CA-based biotech will deploy the money on its AI-based

February 17, 2024

Congress explores changes to the way Medicare pays doctors

Congress is taking early steps towards changing the way Medicare pays physicians. At a hearing Thursday, lawmakers in both parties talked about overhauling a 2015

June 22, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.